Page last updated: 2024-09-05

sb 203580 and Kidney Diseases

sb 203580 has been researched along with Kidney Diseases in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (50.00)29.6817
2010's2 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Coimbra, TM; Costa, RS; Francescato, HD; Silva, CG1
Gao, F; Li, S; Liu, C; Sun, D; Wang, Y; Wang, Z1
Cheng, H; Jiang, D; Jin, N; Wang, Q; Zhang, X; Zhu, K1
Ramesh, G; Reeves, WB1

Other Studies

4 other study(ies) available for sb 203580 and Kidney Diseases

ArticleYear
Treatment with a p38 MAPK inhibitor attenuates cisplatin nephrotoxicity starting after the beginning of renal damage.
    Life sciences, 2009, Apr-24, Volume: 84, Issue:17-18

    Topics: Animals; Antineoplastic Agents; Apoptosis; Cisplatin; Enzyme Activation; Enzyme Inhibitors; Imidazoles; Kidney; Kidney Diseases; Male; Oxidative Stress; p38 Mitogen-Activated Protein Kinases; Pyridines; Rats; Rats, Wistar

2009
Inhibition of p38 mitogen-activated protein kinases attenuates renal interstitial fibrosis in a murine unilateral ureteral occlusion model.
    Life sciences, 2016, Dec-15, Volume: 167

    Topics: Animals; Collagen Type I; Connective Tissue Growth Factor; Disease Models, Animal; Fibrosis; Hypoxia; Hypoxia-Inducible Factor 1, alpha Subunit; Imidazoles; Kidney; Kidney Diseases; Male; Mice; p38 Mitogen-Activated Protein Kinases; Protein Kinase Inhibitors; Pyridines; Transforming Growth Factor beta1

2016
The selective p38 mitogen-activated protein kinase inhibitor, SB203580, improves renal disease in MRL/lpr mouse model of systemic lupus.
    International immunopharmacology, 2011, Volume: 11, Issue:9

    Topics: Alanine Transaminase; Animals; Aspartate Aminotransferases; Complement C3; Creatinine; Female; Hepatocytes; Imidazoles; Immunoglobulins; Kidney; Kidney Diseases; Liver; Lupus Erythematosus, Systemic; Mice; Mice, Inbred C57BL; p38 Mitogen-Activated Protein Kinases; Proteinuria; Pyridines; Spleen

2011
p38 MAP kinase inhibition ameliorates cisplatin nephrotoxicity in mice.
    American journal of physiology. Renal physiology, 2005, Volume: 289, Issue:1

    Topics: Animals; Cell Line; Cisplatin; Enzyme Activation; Enzyme Inhibitors; Free Radical Scavengers; Imidazoles; Kidney Diseases; Male; Mice; Mice, Inbred C57BL; p38 Mitogen-Activated Protein Kinases; Pyridines; Reactive Oxygen Species; Thiazoles; Thiourea; Tumor Necrosis Factor-alpha

2005